Snyder Wins Multi-Drug Contract From Forest Labs.BETHESDA, Md.--(BUSINESS WIRE)--September 14, 1998--Snyder Communications, Inc. (NYSE NYSE See: New York Stock Exchange : SNC SNC St Norbert College (De Pere, Wisconsin) SNC Sistema Nervioso Central SNC Société en Nom Collectif (French: Partnership) SNC Système Nerveux Central (French: central nervous system) ) announced today that it won a new multi-drug pharmaceutical sales contract Sales Contract Contract between a seller and buyer for the sale of goods, services, or both. from Forest Laboratories Inc. (AMEX AMEX See: American Stock Exchange : FRX FRX Frame Relay Exchange (provides backbone connectivity for HUB sites) FRX Frequently Repeated Line FRX Fox Pro Report ). This represents a new client win for Snyder Communications' Healthcare Sales unit. Under the agreement with Forest, Snyder Healthcare Sales will provide national sales detailing and field management for multiple Forest drugs, including Aerobid, an inhaled steroid for the treatment of asthma; Tiazac, a cardiovascular drug; and Monurol, an antibiotic. More than 200 technically trained sales representatives will be dedicated to this effort. Daniel M. Snyder, Chairman and Chief Executive Officer of Snyder Communications Snyder Communications Inc. (SNC) was founded in 1988 by Daniel M. Snyder and his sister Michelle Snyder. Their activities were mainly outsourced marketing services, such as Direct marketing, database marketing, proprietary product sampling, sponsored information display in prime , commented, "We are excited to be working with Forest Laboratories and welcome them to Snyder Healthcare Sales' client base of the world's leading pharmaceutical manufacturers. As with all of our blue chip clients, our established national recruitment network and industry leading sales training services will ensure that Forest receives the highest possible return on investment for this critical program." Snyder Healthcare Sales, Inc., a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Snyder Communications, is the world's leading provider of outsourced pharmaceutical sales and marketing solutions and sales force recruitment services. Snyder Healthcare Sales functions as a total service provider, going beyond traditional contract sales organizations by utilizing other value-added offerings from Snyder Communications' global network, including strategic analysis, consulting services, educational programs, direct-to-consumer advertising direct-to-consumer advertising Drug industry The use of mass media–eg, TV, magazines, newspapers, to publicly promote drugs, medical devices or other products which, by law, require a prescription, which targets consumers, with the intent of having a Pt and sampling services. Snyder Healthcare Sales has longstanding relationships with many of the world's leading pharmaceutical manufacturers, including Bristol Myers Squibb, Eli Lilly Eli Lilly can refer to:
Snyder Communications, Inc. is a leading provider of fully integrated outsourced marketing solutions primarily for Fortune 500 size companies. Snyder identifies high-value market segments; designs and implements marketing programs to reach them; initiates and closes sales on behalf of its clients; and provides customer care, retention and loyalty marketing services. Snyder's resources include proprietary databases of targeted consumers and small businesses; database management services; pharmaceutical detailing services; pharmaceutical consulting; medical educational communications; proprietary product sampling programs and publications; sponsored information displays in proprietary locations; marketing program consultants; creative services; field sales and marketing representatives; customer service representatives; and direct mail and fulfillment capabilities. Snyder has offices throughout the United States, the United Kingdom, France, Ireland and Hungary.
CONTACT: Snyder Communications, Inc.
Clay Perfall
Chief Financial Officer
(301) 571-6270
or
Dewe Rogerson Inc.
David Pasquale (Investors)
Fielding Dupuy (Media)
(212) 688-6840
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion